Authors:
GERSHANOVICH M
CHAUDRI HA
CAMPOS D
LURIE H
BONAVENTURA A
JEFFREY M
BUZZI F
BODROGI I
LUDWIG H
REICHARDT P
OHIGGINS N
ROMIEU G
FRIEDERICH P
LASSUS M
Citation: M. Gershanovich et al., LETROZOLE, A NEW ORAL AROMATASE INHIBITOR - RANDOMIZED TRIAL COMPARING 2.5MG DAILY, 0.5MG DAILY AND AMINOGLUTETHIMIDE IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER, Annals of oncology, 9(6), 1998, pp. 639-645
Authors:
KAYE SB
MEAD GM
FOSSA S
CULLEN M
DEWIT R
BODROGI I
VANGROENINGEN C
SYLVESTER R
COLLETTE L
STENNING S
DEPRIJCK L
LALLEMAND E
DEMULDER P
Citation: Sb. Kaye et al., INTENSIVE INDUCTION-SEQUENTIAL CHEMOTHERAPY WITH BOP VIP-B COMPARED WITH TREATMENT WITH BEP/EP FOR POOR-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - A RANDOMIZED MEDICAL-RESEARCH-COUNCIL EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER STUDY/, Journal of clinical oncology, 16(2), 1998, pp. 692-701
Authors:
FOSSA SD
KAYE SB
MEAD GM
CULLEN M
DEWIT R
BODROGI I
VANGROENINGEN CJ
DEMULDER PHM
STENNING S
LALLEMAND E
DEPRIJCK L
COLLETTE L
Citation: Sd. Fossa et al., FILGRASTIM DURING COMBINATION CHEMOTHERAPY OF PATIENTS WITH POOR-PROGNOSIS METASTATIC GERM-CELL MALIGNANCY, Journal of clinical oncology, 16(2), 1998, pp. 716-724
Authors:
EID H
GECZI L
MAGORI A
BODROGI I
INSTITORIS E
BAK M
Citation: H. Eid et al., DRUG-RESISTANCE AND SENSITIVITY OF GERM-CELL TESTICULAR-TUMORS - EVALUATION OF CLINICAL RELEVANCE OF MDR1 PGP, P53, AND METALLOTHIONEIN (MT) PROTEINS/, Anticancer research, 18(4C), 1998, pp. 3059-3064
Citation: E. Institoris et al., DIFFERENTIAL EXPRESSION OF GLUTATHIONE S-TRANSFERASES IN GERM-CELL TUMORS OF HUMAN TESTES, Anticancer research, 18(3A), 1998, pp. 1727-1731
Authors:
EID H
GECZI L
BODROGI I
INSTITORIS E
BAK M
Citation: H. Eid et al., DO METALLOTHIONEINS AFFECT THE RESPONSE TO TREATMENT IN TESTIS CANCERS, Journal of cancer research and clinical oncology, 124(1), 1998, pp. 31-36
Authors:
EID H
GULYAS M
GECZI L
BODROGI I
INSTITORIS E
BAK M
Citation: H. Eid et al., EXPRESSION OF BCL-2 IN TESTICULAR-CARCINOMA - CORRELATION WITH TUMOR PROGRESSION AND MDR1 PGP/, Cancer, 83(2), 1998, pp. 331-336
Authors:
INSTITORIS E
EID H
BODROGI I
GECZI L
BAK M
Citation: E. Institoris et al., EXPRESSION OF P53, WAF1, MDM2 AND BCL-2 PROTEINS IN HUMAN GERM-CELL TESTICULAR-TUMORS, British Journal of Cancer, 78, 1998, pp. 17-17
Authors:
GEOZI L
LASZLO G
JUHOS E
KATNIZ E
BAKI M
KAROLYI A
BODROGI I
TELEKES A
Citation: L. Geozi et al., MULTICENTER COMPARISON OF INTRAVENOUS GRANISETRON (G) ALONE OR IN COMBINATION WITH DEXAMETHASONE (GD) IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MODERATE AND HIGHLY EMETOGENIC CHEMOTHERAPY (CH) -THE HUNGARIAN EXPERIENCE, European journal of cancer, 33, 1997, pp. 244-244
Authors:
EID H
VANDERLOOIJ M
INSTITORIS E
GECZI L
BODROGI I
OLAH E
BAK M
Citation: H. Eid et al., IS P53 EXPRESSION, DETECTED BY IMMUNOHISTOCHEMISTRY, AN IMPORTANT PARAMETER OF RESPONSE TO TREATMENT IN TESTIS CANCER, Anticancer research, 17(4A), 1997, pp. 2663-2669
Authors:
VANDERLOOIJ M
EID H
BAK M
BODROGI I
OLAH E
Citation: M. Vanderlooij et al., ALLELE LOSS OF TUMOR-SUPPRESSOR GENES ON CHROMOSOME-17 IN HUMAN TESTICULAR GERM-CELL TUMORS, International journal of oncology, 9(5), 1996, pp. 1087-1090
Citation: H. Eid et al., MULTIDRUG-RESISTANCE OF TESTIS CANCERS - THE STUDY OF CLINICAL RELEVANCE OF P-GLYCOPROTEIN EXPRESSION, Anticancer research, 16(6B), 1996, pp. 3447-3452
Citation: E. Institoris et al., GLUTATHIONE-RELATED ENZYMES IN HUMAN TESTICULAR GERM-CELL TUMORS AND NORMAL TESTES, Anticancer research, 15(4), 1995, pp. 1371-1374
Authors:
KIRSCHNER R
KULHAVI C
BODROGI I
BOKI M
SIKLOS P
BAKACS T
Citation: R. Kirschner et al., ENHANCED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN PATIENTS WITH GERMINAL CELL TUMORS, Journal of experimental & clinical cancer research, 13(1), 1994, pp. 61-65
Citation: M. Babosa et al., A STUDY OF CHILDREN, FATHERED BY MEN TREATED FOR TESTICULAR CANCER, CONCEIVED BEFORE, DURING, AND AFTER CHEMOTHERAPY, Medical and pediatric oncology, 22(1), 1994, pp. 33-38